Bicyclic heteroaromatic compounds as kinase inhibitors

Details for Australian Patent Application No. 2003252990 (hide)

Owner UCB Pharma S.A.

Inventors Brookings, Daniel Christopher; Langham, Barry John; Davis, Jeremy Martin

Agent Watermark

Pub. Number AU-B-2003252990

PCT Number PCT/GB03/03501

PCT Pub. Number WO2004/014920

Priority 0218800.1 13.08.02 GB

Filing date 11 August 2003

Wipo publication date 25 February 2004

Acceptance publication date 9 July 2009

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/06 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 0218800.1 13.08.02 GB

8 April 2004 Application Open to Public Inspection

  Published as AU-B-2003252990

14 February 2008 Assignment before Grant

  Celltech R&D Limited The application has been assigned to UCB Pharma S.A.

9 July 2009 Application Accepted

  Published as AU-B-2003252990

5 November 2009 Standard Patent Sealed

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003252991-INTERFERON-Alpha INDUCED GENE

2003252989-PAYMENT CARD PROCESSING METHOD AND APPARATUS